Your institution may have access to this item. Find your institution then sign in to continue.
Title
Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncology.
Authors
Ou SH; Bartlett CH; Mino-Kenudson M; Cui J; Iafrate AJ